Skip to main content

Verition Fund Management LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1454027 GREENWICH, CT

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
400,000
+318.4% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 400,000
2025-06-30 95,605
2025-03-31 110,510
2024-12-31 50,410
2023-06-30 3,997
2023-03-31 3,650
2022-06-30 5,259
2022-03-31 52,899
2021-12-31 84,493
2021-06-30 19,477
2021-03-31 14,102
2020-06-30 99,045
2020-03-31 41,389